» Articles » PMID: 14745950

Properties of Four Human Embryonic Stem Cell Lines Maintained in a Feeder-free Culture System

Overview
Journal Dev Dyn
Publisher Wiley
Date 2004 Jan 28
PMID 14745950
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Several laboratories have begun evaluating human ES (hES) cell lines; however, direct comparisons between different hES cell lines have not been performed. We have characterized the properties of four human cell lines maintained in feeder-free culture conditions. Quantitative assessment of surface markers, microarray analysis of gene expression patterns, expression of SOX-2, UTF-1, Rex-1, OCT3/4, CRIPTO, and telomerase activity demonstrated similar patterns in all hES cell lines examined. Undifferentiated hES cells do not respond to neurotransmitters such as acetylcholine, glutamate, and gamma-aminobutyric acid. In addition, the undifferentiated hES cells possess gap junctions. Although similarities in marker expression were observed, allotyping showed that all four lines have a distinct HLA profile, predicting differences in transplantation responses. These data provide the first detailed comparison of different hES cell lines and demonstrate remarkable similarities among lines maintained in identical culture conditions.

Citing Articles

A short history of pluripotent stem cells markers.

Andrews P, Gokhale P Stem Cell Reports. 2023; 19(1):1-10.

PMID: 38157849 PMC: 10828816. DOI: 10.1016/j.stemcr.2023.11.012.


Connexin 43 Gene Ablation Does Not Alter Human Pluripotent Stem Cell Germ Lineage Specification.

Christopher G, Noort R, Esseltine J Biomolecules. 2022; 12(1).

PMID: 35053163 PMC: 8773696. DOI: 10.3390/biom12010015.


Connexins in the development and physiology of stem cells.

Ngezahayo A, Ruhe F Tissue Barriers. 2021; 9(4):1949242.

PMID: 34227910 PMC: 8794508. DOI: 10.1080/21688370.2021.1949242.


Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes.

Wszola M, Nitarska D, Cywoniuk P, Gomolka M, Klak M Cells. 2021; 10(6).

PMID: 34207441 PMC: 8234129. DOI: 10.3390/cells10061544.


Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells.

Yang W, Kim D, Kim D, Choi K, Suh D, Kim J Int J Mol Sci. 2021; 22(10).

PMID: 34064635 PMC: 8151268. DOI: 10.3390/ijms22105059.